NCT04888507
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Regeneron Study Site Leeds, United Kingdom
Clinical trial condition
Hemoglobinuria, Paroxysmal
Explore clinical trials studying Hemoglobinuria, Paroxysmal. Study availability and eligibility vary by location and protocol.
166 public trials
28 recruiting studies
Hemoglobinuria, Paroxysmal trial results
NCT07035665
- Conditions
- Anemia, Anemia, Hemolytic, Autoimmune Diseases, +17 more
- Locations
-
- ZhongShan Hospital FuDan University Shanghai, Shanghai Municipality, China
NCT06050226
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
NCT06561841
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
NCT06987864
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Territorial State Budgetary Healthcare Institution "Territorial Clinical Hospital" Barnaul, Russia
- State Autonomous Healthcare Institution "S.V. Belyaev Kuzbass Regional Clinical Hospital" Kemerovo, Russia
- Federal State Budgetary Institution of Science "Kirov Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency" Kirov, Russia
- Moscow State Budgetary Healthcare Institution "S.P. Botkin Municipal Clinical Hospital of the Moscow Healthcare Department" Moscow, Russia
NCT02534909
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Novartis Investigative Site Brno-Bohunice, Czech Republic, Czechia
- Novartis Investigative Site Fukushima, Japan
- Novartis Investigative Site Isehara, Kanagawa, Japan
- Novartis Investigative Site Suita, Osaka, Japan
NCT04469465
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +8 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Weston, Florida, United States
- Research Site Chicago, Illinois, United States
- Research Site Kalamazoo, Michigan, United States
Completed
Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
NCT03427060
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT03588026
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Almaty City Hospital No.7 Almaty, Microdistrict Kalkaman, Kazakhstan
- Vilnius University Hospital Santaros Klinikos , Santariškių St. 2, LT-08661, Vilnius, Lithuania
- University of Kelaniya, Faculty of Medicine, Thalagolla Road Colombo, Sri Lanka
NCT04811716
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Prince of Wales Hospital Hong Kong, New Territories
- D l Pesti Centrumk rh z Orsz gos Hematol giai s Infektol giai Int zet Budapest, Nagyvárad Tér 1, Hungary
- Hospital Miri Miri, Sarawak, Malaysia
- Hospital Sibu Sibu, Sarawak, Malaysia